Audio
FDA Commissioner Dr. Robert Califf on Bivalent COVID-19 Vaccines, Combating Misinformation, and Building Trust
Organization: Johns Hopkins Bloomberg School of Public HealthPublished: 2022
"Throughout COVID-19, the FDA has been among many government agencies charged with communicating lifesaving information. Commissioner Dr. Robert Califf talks with Dr. Josh Sharfstein about how the politicization of the pandemic raised the stakes for the FDA and how the agency is learning to adapt in an age of rampant misinformation. They also discuss the FDA’s consideration of bivalent vaccines for authorization and what’s next for the pandemic response." - FDA Commissioner Dr. Robert Califf on Bivalent COVID-19 Vaccines, Combating Misinformation, and Building Trust
Resource Group:
Background Knowledge
Product Type: Podcast
Sub Topics: Vaccination Decision Making
Misinformation/Disinformation
Monitoring and Surveillance
Outbreaks and Pandemics
COVID-19
Product Type: Podcast
Category:
Vaccination Decision Making,Sub Topics: Vaccination Decision Making,Misinformation/Disinformation,Monitoring and Surveillance,Outbreaks and Pandemics,COVID-19 Vaccination Decision MakingSub Topics: Vaccination Decision Making
Misinformation/Disinformation
Monitoring and Surveillance
Outbreaks and Pandemics
COVID-19
Language:
English
Resource Rating Breakdown
Ratings submitted by CANVax users for this resource are tallied to provide an average resource rating per category.
0 Comments
Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.
All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.
You must login or register before you can submit a comment.